We are proud to announce the final program and speakers for the 5th Discngine Meetup, which will take place in just two weeks, on October 16!
Join us for a two-hour virtual event that will cover presentations and offer a roundtable discussion with industry leaders from AstraZeneca, Merck & Co., Novartis, and others on the latest advancements in science and technology for efficient Peptide Drug Discovery.
Secure your spot today and don’t miss the opportunity to engage with experts driving progress in peptide drug discovery.
The recent release of 3dpredict/Ab introduces several major updates, most notably:
Reference Collections: You can now build your desired reference collection of any molecule previously analyzed and use it as a reference for a current analysis. The collection is then integrated into the whole protein property reports, enabling direct visual comparison and filtering of new results against known benchmarks.
Support for ADCs and more: 3dpredict/Ab now supports property predictions for non-standard antibody architectures, including antibody-drug conjugates (ADCs) and other complex constructs, the same way it does for standard anybodies.
New protein property plots, analysis visualization, and more.
The collaboration between Bayer and Discngine has led to the successful development of a modern tool for efficient Structure-Activity Relationship (SAR) report generation and analysis:Discngine Ideation SAR Slides.
Aurélie Mallinger, Laboratory and Project Leader at Bayer Crop Science, will join the Chemical Computing Group (CCG)’s byDesign event in Basel to present the added value that this tool brings to discovery chemists, and insights into future developments.
Over the past quarter, we have been exploring the structural aspects of the TREM2 target in Alzheimer’s disease and strategies for antibody optimization. One particularly interesting approach comes from Roche scientists applying a parallel lineage repertoire mining method for rational affinity optimization.
You’re receiving this message because you’ve either participated in one of Discngine’s events, subscribed via our website or opted in to receive updates, requested information from us - either in person, online, or through written communication, or your organization has licensed one of Discngine’s products or solutions.
